It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Centers for Disease Control and Prevention said on Thursday that about 265.6 million people had received at least one dose of a Covid-19 vaccine, including about 226.6 million people who had been fully vaccinated by the Johnson & Johnson single-dose vaccine or the two-dose series made by Pfizer-BioNTech and Moderna.
The C.D.C. also reported that about 111.4 million fully vaccinated people have received an additional vaccine dose or a booster dose, and that approximately 19.4 million had gotten the updated bivalent booster shot, the highest level of protection against the virus.
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023
Pfizer will charge as much as $130 for Comirnaty, which costs an estimated $1.18 per dose to produce
For over two years now, the US government has purchased all of the covid vaccines administered in the country, in what has become the largest public vaccination campaign in American history.
Those purchases have included more than 500 million doses from Pfizer. The first 100 million cost around $20 a dose, thanks to an earlier agreement in which the US government invested $1.95 billion in vaccine production. The remaining doses were bought for around $30 each.
But once the US government supplies run out (likely in the first quarter of 2023) and covid vaccines and therapeutics are moved onto commercial health platforms, Pfizer is able to hike up the price of its shots.
The company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose.
This is about four times the current selling price—and 100 times the estimated cost of manufacturing the vaccine.
Why Pfizer is raising the price of its covid-19 vaccine
“There are key differences between an emergency and traditional model that increase the costs of making and distributing the COVID-19 vaccine,” Pfizer told Quartz via email. These costs, the company says, include distributing through multiple channels and payers instead of one, as well as producing the doses in single vials, which can be up to three times more expensive and run into higher transportation costs.
Pfizer also says it is the company’s expectation that most privately insured patients will continue not to face out-of-pocket costs for the vaccine, and that it will provide financial assistance to uninsured patients so they can continue to receive the vaccine for free.
About 11.5 million Americans have received the updated bivalent COVID-19 booster, according to data from the Centers for Disease Control and Prevention.
The booster was rolled out at the beginning of September with the Pfizer booster approved for those aged 12 and older and the Moderna booster approved for those aged 18 and older.
MORE: FDA authorizes updated bivalent COVID-19 booster for children aged 5 and older
This expanded to use among those aged 5 and older for the Pfizer booster and aged 6 and older for the Moderna booster Monday.
Experts told ABC News that while it's great many Americans have gotten the new booster, they are worried uptake is not as high as it should be ahead of the colder weather months, when COVID-19 typically spreads much more quickly.
originally posted by: putnam6
It was always about the benjamins, this has made big Pharma and certain politicians filthy rich. Got to ask how many are still getting boosters. '
Thoughts ATS?
qz.com...
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023
Pfizer will charge as much as $130 for Comirnaty, which costs an estimated $1.18 per dose to produce
For over two years now, the US government has purchased all of the covid vaccines administered in the country, in what has become the largest public vaccination campaign in American history.
Those purchases have included more than 500 million doses from Pfizer. The first 100 million cost around $20 a dose, thanks to an earlier agreement in which the US government invested $1.95 billion in vaccine production. The remaining doses were bought for around $30 each.
But once the US government supplies run out (likely in the first quarter of 2023) and covid vaccines and therapeutics are moved onto commercial health platforms, Pfizer is able to hike up the price of its shots.
The company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose.
This is about four times the current selling price—and 100 times the estimated cost of manufacturing the vaccine.
Why Pfizer is raising the price of its covid-19 vaccine
“There are key differences between an emergency and traditional model that increase the costs of making and distributing the COVID-19 vaccine,” Pfizer told Quartz via email. These costs, the company says, include distributing through multiple channels and payers instead of one, as well as producing the doses in single vials, which can be up to three times more expensive and run into higher transportation costs.
Pfizer also says it is the company’s expectation that most privately insured patients will continue not to face out-of-pocket costs for the vaccine, and that it will provide financial assistance to uninsured patients so they can continue to receive the vaccine for free.
originally posted by: lordcomac
Well now that they're going to be mandatory for children to get for public school, the price doesn't matter- low income families will still get them paid for by taxes and the rich can afford it
Oct. 18, 2022 -- Adults over 50, and particularly those over 65, should get omicron booster shots right away, the head of the White House COVID-19 task force said this week.
“If you’re over 50, certainly if you’re over 65, you’ve got to go get these vaccines because it actually, literally could save your life. It’s a difference between life and death,” Ashish Jha, MD, said.
An average of 330 people a day die from COVID, according to the CDC. About 70% of people who die from it are 75 and older, Jha said.
He said people dying from COVID-19 didn’t stay up to date on vaccines or didn’t receive antiviral treatments after breakthrough infections.
originally posted by: v1rtu0s0
originally posted by: putnam6
It was always about the benjamins, this has made big Pharma and certain politicians filthy rich. Got to ask how many are still getting boosters. '
Thoughts ATS?
qz.com...
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023
Pfizer will charge as much as $130 for Comirnaty, which costs an estimated $1.18 per dose to produce
For over two years now, the US government has purchased all of the covid vaccines administered in the country, in what has become the largest public vaccination campaign in American history.
Those purchases have included more than 500 million doses from Pfizer. The first 100 million cost around $20 a dose, thanks to an earlier agreement in which the US government invested $1.95 billion in vaccine production. The remaining doses were bought for around $30 each.
But once the US government supplies run out (likely in the first quarter of 2023) and covid vaccines and therapeutics are moved onto commercial health platforms, Pfizer is able to hike up the price of its shots.
The company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose.
This is about four times the current selling price—and 100 times the estimated cost of manufacturing the vaccine.
Why Pfizer is raising the price of its covid-19 vaccine
“There are key differences between an emergency and traditional model that increase the costs of making and distributing the COVID-19 vaccine,” Pfizer told Quartz via email. These costs, the company says, include distributing through multiple channels and payers instead of one, as well as producing the doses in single vials, which can be up to three times more expensive and run into higher transportation costs.
Pfizer also says it is the company’s expectation that most privately insured patients will continue not to face out-of-pocket costs for the vaccine, and that it will provide financial assistance to uninsured patients so they can continue to receive the vaccine for free.
Its because they have to make up for the drop off in injections. So basically they expect a 100x decrease in injections, so jack the price up 100x to make up for it.
Makes sense that people don't want to inject experimental poison.
originally posted by: infolurker
originally posted by: v1rtu0s0
originally posted by: putnam6
It was always about the benjamins, this has made big Pharma and certain politicians filthy rich. Got to ask how many are still getting boosters. '
Thoughts ATS?
qz.com...
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023
Pfizer will charge as much as $130 for Comirnaty, which costs an estimated $1.18 per dose to produce
For over two years now, the US government has purchased all of the covid vaccines administered in the country, in what has become the largest public vaccination campaign in American history.
Those purchases have included more than 500 million doses from Pfizer. The first 100 million cost around $20 a dose, thanks to an earlier agreement in which the US government invested $1.95 billion in vaccine production. The remaining doses were bought for around $30 each.
But once the US government supplies run out (likely in the first quarter of 2023) and covid vaccines and therapeutics are moved onto commercial health platforms, Pfizer is able to hike up the price of its shots.
The company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose.
This is about four times the current selling price—and 100 times the estimated cost of manufacturing the vaccine.
Why Pfizer is raising the price of its covid-19 vaccine
“There are key differences between an emergency and traditional model that increase the costs of making and distributing the COVID-19 vaccine,” Pfizer told Quartz via email. These costs, the company says, include distributing through multiple channels and payers instead of one, as well as producing the doses in single vials, which can be up to three times more expensive and run into higher transportation costs.
Pfizer also says it is the company’s expectation that most privately insured patients will continue not to face out-of-pocket costs for the vaccine, and that it will provide financial assistance to uninsured patients so they can continue to receive the vaccine for free.
Its because they have to make up for the drop off in injections. So basically they expect a 100x decrease in injections, so jack the price up 100x to make up for it.
Makes sense that people don't want to inject experimental poison.
Oh, only if they could bribe the CDC, FDA, and Politicians to make these shots MANDATORY some how.....
Imagine the profits!